🔎 Trials Near Me

Beranda › Kanker (semua jenis) › New York

Uji klinis Kanker (semua jenis) di New York

142 studi untuk Kanker (semua jenis) mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer

  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • dan 1 lainnya
Menerima peserta
Usia 18 hingga 39 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07855484

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

  • GSK Investigational Site, Rochester
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06796907

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  • SUNY Upstate Medical University - Syracuse /ID# 277305, Syracuse
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 1 Okt 2026 · NCT07024784

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Roswell Park Cancer Institute, Buffalo
  • Columbia University - Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • dan 1 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05382559

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07192471

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • The Feinstein Institutes for Medical Research, Lake Success
  • NYU Grossman School of Medicine, New York
  • SUNY Upstate, Syracuse
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05874921

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07410117

Registry Study for Radiation Therapy Outcomes

  • New York Proton Center, New York
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT01255748

A Study of Music Therapy for Anxiety in People With Cancer

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
  • dan 1 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07845422

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07493304

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

  • Investigative Site, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06881992

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

  • GSK Investigational Site, New Hyde Park
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07277270

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • Westchester Medical Center, Valhalla
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07195591

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • NYU Langone Medical Center, New York
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119

A Study of JNJ-1761981 in Participants With Solid Tumors

  • Montefiore Medical Center, The Bronx
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07525141

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

  • Rockefeller Outpatient Pavilion ( Site 0002), New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06979596

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Icahn School of Medicine at Mount Sinai, New York
  • University of Rochester Medical Center, Rochester
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

  • NYU Langone Health, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06311578

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07612176

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  • Memorial Sloan Kettering Cancer Center ( Site 4010), New York
  • New York Medical College ( Site 4023), Valhalla
Menerima pesertaFase 1/2
1 Month – 17 Years · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06150157

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • NYU Langone Medical Center, New York
  • Montefiore Medical Center, The Bronx
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06901531

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

  • Columbia University Irving Medical Center, New York
Menerima peserta
Usia 15 hingga 24 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07223463

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 4, Buffalo
  • Quetzal Site 2, The Bronx
Menerima pesertaFase 3
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458

Pan Tumor Rollover Study

  • NYU Langone Hematology Oncology Associates-Mineola, Mineola
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03899155

Intratumoral N17350 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07339176

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Northwell Health Monter Cancer Center, Lake Success
  • Northern Westchester Hospital, Mount Kisco
  • Cohen Children's Medical Center, New Hyde Park
  • dan 4 lainnya
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

  • Roswell Park Comprehensive Cancer Center, Buffalo
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06423950

Prospective Study to Assess a Diagnostic Aid for Cancer

  • Westchester Putnam Gastro, Carmel
  • Associated Gastroenterologists of Central New York, Fayetteville
  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaStudi observasional
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07046260

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • City College of New York (Data Collection AND Data Analysis), New York
  • dan 3 lainnya
Menerima pesertaStudi observasional
Usia 21 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT01742143

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • New York Oncology Hematology P.C., Albany
  • Roswell Park Cancer Institute, Buffalo
  • New York University - Langone Medical Center - The Center for Musculoskeletal Care, New York
  • dan 4 lainnya
Menerima pesertaFase 2/3
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

  • Memorial Sloan Kettering Cancer Center ( Site 3010), New York
  • New York Medical College ( Site 3023), Valhalla
Menerima pesertaFase 1/2
1 Month – 17 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06941272

Collection of Tissue Samples for Cancer Research

  • Roswell Park Cancer Institute, Buffalo
Menerima pesertaStudi observasional
2 Months · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00900198

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Roswell Park Center Institute, Buffalo
  • NYU Langone Health, New York
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06756607

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06953960

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Commack
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05123482

Exercise and Cognitive Rehab in Older Cancer Survivors

  • University of Rochester, Rochester
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05388214

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • Icahn School of Medicine At Mount Sinai, New York
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • dan 2 lainnya
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06634589

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.